The company said it held its April 17, 2025 regular annual stockholders meeting, and that holders of 105,203,172 shares of common stock attended by valid proxy, constituting a quorum. It said three proposals were voted on at the meeting.

1. 01

   The company said it held its April 17, 2025 regular annual stockholders meeting, and that holders of 105,203,172 shares of common stock attended by valid proxy, constituting a quorum. It said three proposals were voted on at the meeting.

2. 02

   Humana said all 11 director nominees were elected to the board. Raquel C. Bono, M.D. received 99,603,400 votes for and 353,601 against, while Karen W. Katz received 93,912,129 votes for and 6,040,964 against.

3. 03

   The company said its stockholders approved the appointment of PricewaterhouseCoopers LLP as independent external auditor for the fiscal year ending December 31, 2025. The voting results were 98,877,049 votes for, 6,290,061 against and 36,062 abstentions.

4. 04

   The company said stockholders approved the non-binding advisory vote on executive compensation. The voting results were 89,310,631 votes for, 10,567,799 against, 131,538 abstentions and 5,193,204 broker non-votes.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.